Reversal effect of cinobufacine on adriamycin resistancehuman breast cancer cells

Chinese Pharmacological Bulletin

Volumn 23, Issue 5, 2007, Pages

  Wang, Ling ^a   Liu, Shi Kun ^b   Zhou, Yu Lu ^b   Pei, Qi ^b  

^a Yongzhou Vocation Technical College   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adriamycin; Cinobufacine; MCF 7 ADM; Multidrug resistance

Indexed keywords

ANTINEOPLASTIC AGENT; CINOBUFACINE; DOXORUBICIN; GLYCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CYTOTOXICITY; DOSE RESPONSE; DRUG RESISTANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LETHAL DOSE; PROTEIN EXPRESSION; REVERSAL REACTION;

EID: 34547787710     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hou L, Chen X Y. Reversion of multi-drug resistance of tumors using Chinese medicine and its prospects[J]. Chin J Basic Med Trad Chin Med, 2004,10(4)79-82.
2. Hu J, Zhao J Y, Yang P M, et al. Reversal effect of β-elemene on mutidrug resistance in human tumor cells MCF-7/ADM[J]. Chin J Microecol, 2002,14(4):214-5.
3. Niu J Z, He F J, Li Y, et al. Effects of genistein on expression of VEGF in human breast cancer cell lines[J]. Chin Pharmacol Bull, 2006,22(7):873-5.
4. Scambia G, Ranelletti F O, Panici P B, et al. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycuprotein as a possible target[J]. Cancer Chemother Pharmacol, 1994,34:459-62.
5. Zhang L, Li J, Guo W J. Progress in the study for mechanisms of multidrug resistance in breast cancer[J]. Chin J Cancer Prev Treat, 2004,11(2):199-201.
6. Qu C H. Cinobufacine injection pharmaco-research and clinical application[J]. Shi Zhen Med Mat Med Res, 1999,10(5):382.